Optimal use of glucose polymer (icodextrin) in peritoneal dialysis

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Mistry, Chandra D ^a   Gokal, Ram ^a  

^a PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Colloid; Dextrin; Glucose; Glucose polymer; Icodextrin; Maltose; Osmosis; Ultrafiltration

Indexed keywords

GLUCOSE POLYMER; OSMOTIC AGENT;

BODY WATER; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; OSMOSIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0029893746     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s18     Document Type: Conference Paper

References (23)

1. Hain H, Kessel M. Aspect of new solutions for peritoneal dialysis. Nephrol Dial Transplant 1987; 2:67-72.
2. Ota K, Mineshima M, Watanabe N, Naganuma S. Functional deterioration of the peritoneum: does it occur in the absence of peritonitis? Nephrol Dial Transplant 1987; 2:30-3.
3. Dobbie JW. New concepts of molecular biology and ultrastructural pathology of the peritoneum; their significance for peritoneal dialysis. Am J Kidney Dis 1990; 15:97-109.
4. Lamb E, Cattell WR, Dawnay A. Glycated albumin in serum and dialysate of patients on CAPD. Clin Sci 1993; 84:619-26.
5. Kiil F. Mechanism of osmosis. Kidney Int 1982; 21:303-8.
6. Mistry CD, Gokal R. The use of glucose polymer in CAPD: essential physiological and clinical conclusions. In: Ota K, Maher JF, Winchester JF, Hirszel P, eds. Current concepts in peritoneal dialysis. Amsterdam: Elsevier Science Publishers, 1993:138-42.
7. Mistry CD, Mallick NP, Gokal R. Ultrafiltration with isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987; ii:178-82.
8. Mistry CD, Gokal R. A single daily overnight (12 hr dwell) use of 7.5% glucose polymer (Mw 18,700; Mn 7,300) + 0.35% glucose solution: a 3 month study. Nephrol Dial Transplant 1993; 8:443-7.
9. Mistry CD, Gokal R, Peers MA, Midas Study Group. A randomised multicentre clinical trial comparing isosmolar dextrin 20 with hyperosmolar glucose solutions in continuous ambulatory peritoneal dialysis (CAPD): a six month study. Kidney Int 1994; 46:496-503.
10. Posthuma N, Wee PM , Donker AJM, Oe PL, Verbrugh HA. Improved ultrafiltration in CCPD patients using a glucose polymer (GP) instead of glucose (G) as last bag. Kidney Int (in press).
11. McArdle CS, Kerr DJ, O'Gorman P, et al. Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. Br J Cancer 1994:762-6.
12. Mistry CD. Glucose polymer as an osmotic agent in continuous peritoneal dialysis. (MD Thesis) London: University of London, 1989:1-300.
13. Mistry CD, Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis? The role for "colloid" osmosis. Clin Sci 1993; 85:495-500.
14. Weser E, Sleisenger MH. Metabolism of circulating disaccharides in man and in the rat. J Clin Invest 1967; 46:499-505.
15. Van Handle E. Trehalase and maltase in the serum of vertebrates. Comp Biochem Physiol 1968; 26:555-61.
16. Bittencourt H, Sleisenger MH, Weser E. Studies of serum and tissue maltase in the rat. Gastroenterology 1968; 57:410.
17. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34:404-11.
18. Alobaidi HM, Coles GA, Davies M, Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function Nephrol Dial Transplant 1986; 1:16-21.
19. Liberek T, Topley N, Mistry CD,et al. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit Dial Int 1993; 13:104-11.
20. DeFijter CWA, Verbrugh HA, Oe PL, et al. Biocompatibility of a glucose polymer containingperitoneal dialysis fluid. Am J Kidney Dis 1993; 21:411-18.
21. Rooney OB, Smyth JV, Hilker VF, Gokal R, Walker MG. Glucose polymer in peritoneal dialysis - in vitro mesothelial cell study. (Abstract) Nephrol Dial Transplant 1994; 9(7):858.
22. Jorres A, Gahl GM, Topley N, et al. In vitro biocompatibility of alternative CAPD fluids: comparison of biocarbonate buffered glucose and glucose polymer based solutions. Nephrol Dial Transplant 1994; 9(7):785-90.
23. Stein A, Peers E, Hattersley J, Harris K, Feehally J, Walls J. Clinical experience with icodextrin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14 (Suppl 2):S51-S54.